| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74495 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76298-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76799-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76740SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77234-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-41209-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64849SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-71059 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64358-0.2mg | |||
| BSA Free | NB100-64358-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-63062-0.025mg | |||
![Western Blot: TGF-beta 1 Antibody (OTI1E12) [NBP2-46108] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TGF-beta 1.](http://images.novusbio.com/fullsize/TGF-beta-1-Antibody-OTI1E12-Western-Blot-NBP2-46108-img0004.jpg "Western Blot: TGF-beta 1 Antibody (OTI1E12) [NBP2-46108] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TGF-beta 1.")
![Flow Cytometry: TGF-beta 1 Antibody (OTI1E12) [NBP2-46108] - Analysis of SF295 cells, using TGFB1 antibody,(Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/TGF-beta-1-Antibody-OTI1E12-Flow-Cytometry-NBP2-46108-img0001.jpg)
![Immunofluorescence: TGF-beta 1 Antibody (OTI1E12) [NBP2-46108] - Analysis of COS7 cells transiently transfected by pCMV6-ENTRY TGF-Beta 1.](http://images.novusbio.com/fullsize/TGF-beta-1-Antibody-OTI1E12-Immunofluorescence-NBP2-46108-img0002.jpg)
![Immunofluorescence: TGF-beta 1 Antibody (OTI1E12) [NBP2-46108] - Analysis of HeLa cells.](http://images.novusbio.com/fullsize/TGF-beta-1-Antibody-OTI1E12-Immunofluorescence-NBP2-46108-img0003.jpg)
![Western Blot: Importin alpha 2/KPNA2 Antibody [NBP1-76298] - Western blot analysis of KPNA2 expression in Daudi cell lysate with KPNA2 antibody at (A) 1 and (B) 2 ug/ml.](http://images.novusbio.com/fullsize/Importin-alpha-2-KPNA2-Antibody-Western-Blot-NBP1-76298-img0005.jpg "Western Blot: Importin alpha 2/KPNA2 Antibody [NBP1-76298] - Western blot analysis of KPNA2 expression in Daudi cell lysate with KPNA2 antibody at (A) 1 and (B) 2 ug/ml.")
![Western Blot: Importin alpha 2/KPNA2 Antibody [NBP1-76298] - Rat heart tissue lysate with KPNA2 antibody at (A) 1 and (B) 2 ug/mL.](http://images.novusbio.com/fullsize/Importin-alpha-2-KPNA2-Antibody-Western-Blot-NBP1-76298-img0001.jpg)
![Immunohistochemistry: Importin alpha 2/KPNA2 Antibody [NBP1-76298] - Immunohistochemistry of KPNA2 in human heart tissue with KPNA2 antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/Importin-alpha-2-KPNA2-Antibody-Immunohistochemistry-NBP1-76298-img0003.jpg)
![Immunocytochemistry/ Immunofluorescence: Importin alpha 2/KPNA2 Antibody - BSA Free [NBP1-76298] - Immunofluorescence of Importin alpha 2/KPNA2 in human heart tissue with Importin alpha 2/KPNA2 antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp1-76298_rabbit-polyclonal-importin-alpha-2-kpna2-antibody-2711202419432251.jpg)
![Western Blot: IKK gamma Antibody [NBP1-76799] - Analysis of IKKg in HeLa whole cell lysate with anti-IKKg/NEMO using NBP1-76799 at 1 ug/ml.](http://images.novusbio.com/fullsize/IKK-gamma-Antibody-Western-Blot-NBP1-76799-img0003.jpg "Western Blot: IKK gamma Antibody [NBP1-76799] - Analysis of IKKg in HeLa whole cell lysate with anti-IKKg/NEMO using NBP1-76799 at 1 ug/ml.")
![Immunocytochemistry/ Immunofluorescence: IKK gamma Antibody - BSA Free [NBP1-76799] - Immunofluorescence of IKK gamma in Hela cells with IKK gamma antibody at 20 u/mL.Red: IKK gamma Antibody Blue: DAPI staining](http://images.novusbio.com/fullsize/nbp1-76799_rabbit-polyclonal-ikk-gamma-antibody-2711202420175134.gif)
![Immunocytochemistry/ Immunofluorescence: IKK gamma Antibody - BSA Free [NBP1-76799] - Immunocytochemistry of IKK gamma in HeLa cells with IKK gamma antibody at 5 u/mL.](http://images.novusbio.com/fullsize/nbp1-76799_rabbit-polyclonal-ikk-gamma-antibody-2711202419261832.jpg)
![Western Blot: IL-21 Antibody [NBP1-76740] - Western Blot Validation with Recombinant Protein.Loading: 30 ng of human IL-21 recombinant protein per lane.Antibodies: IL-21 NBP1-76740 (0.5 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/IL-21-Antibody-Western-Blot-NBP1-76740-img0007.jpg "<b>Expression of Tagged Proteins Validation. </b>Western Blot: IL-21 Antibody [NBP1-76740] - Western Blot Validation with Recombinant Protein.Loading: 30 ng of human IL-21 recombinant protein per lane.Antibodies: IL-21 NBP1-76740 (0.5 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.")
![<b>Expression of Tagged Proteins Validation. </b>Immunocytochemistry/Immunofluorescence: IL-21 Antibody [NBP1-76740] - Immunocytochemistry Validation of IL-21 in K562 Cells.Immunocytochemical analysis of K562 cells using anti-IL-21 antibody (NBP1-76740) at 2 ug/mL. Cells were fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4 C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.](http://images.novusbio.com/fullsize/IL-21-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-76740-img0008.jpg)
![Western Blot: IL-21 Antibody [NBP1-76740] - Western Blot Validation in Human, Mouse and Rat Cell Lines.Loading: 15 ug of lysates per lane.Antibodies: IL-21 NBP1-76740, (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/IL-21-Antibody-Western-Blot-NBP1-76740-img0004.jpg)
![<b>Independent Antibodies Validation. </b>Western Blot: IL-21 Antibody [NBP1-76740] - Independent Antibody Validation (IAV) via Protein Expression Profile in Cell Lines.Loading: 15 ug of lysates per lane.Antibodies: IL-21 NBP1-76740 (1 ug/mL), IL-21 from Company B (5 ug/mL), beta-actin (5 ug/mL) and beta-actin (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/IL-21-Antibody-Western-Blot-NBP1-76740-img0005.jpg)
![Western Blot: IL-21 Antibody - BSA Free [NBP1-76740] - Figure 3 Western Blot Validation in Human HL-60 Cell LysateLoading: 15 u of lysates per lane.Antibodies: IL-21 (1 u/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.(A) Absence of blocking peptide(B) Presence of blocking peptide.](http://images.novusbio.com/fullsize/nbp1-76740_rabbit-polyclonal-il-21-antibody-271120241937752.jpg)
![Western Blot: BAFFR/TNFRSF13C Antibody [NBP1-77234] - Human (H), mouse (M), and rat (R) spleen tissue lysates with BAFF Receptor antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/BAFFR-TNFRSF13C-Antibody-Western-Blot-NBP1-77234-img0002.jpg "Western Blot: BAFFR/TNFRSF13C Antibody [NBP1-77234] - Human (H), mouse (M), and rat (R) spleen tissue lysates with BAFF Receptor antibody at 5 ug/ml.")
![Immunohistochemistry: BAFFR/TNFRSF13C Antibody - BSA Free [NBP1-77234] - Immunohistochemistry of BAFF Receptor in human tonsil tissue with BAFF Receptor antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77234_rabbit-polyclonal-baffr-tnfrsf13c-antibody-2711202420212393.jpg)
![Immunohistochemistry: BAFFR/TNFRSF13C Antibody - BSA Free [NBP1-77234] - Immunohistochemistry of BAFFR/TNFRSF13C in human spleen tissue with BAFFR/TNFRSF13C antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77234_rabbit-polyclonal-baffr-tnfrsf13c-antibody-2711202419241377.gif)
![Immunocytochemistry/ Immunofluorescence: BAFFR/TNFRSF13C Antibody - BSA Free [NBP1-77234] - Immunofluorescence of BAFFR/TNFRSF13C in human spleen tissue with BAFFR/TNFRSF13C antibody at 20 ug/ml.Red: BAFF Receptor Antibody Blue: DAPI staining](http://images.novusbio.com/fullsize/nbp1-77234_rabbit-polyclonal-baffr-tnfrsf13c-antibody-2711202420141949.gif)
![Western Blot: CCL2/MCP1 Antibody [NBP2-41209] - Analysis of CCL2 in K562 cell lysate with CCL2 antibody at 1 ug/mL.](http://images.novusbio.com/fullsize/CCL2-MCP1-Antibody-Western-Blot-NBP2-41209-img0005.jpg "Western Blot: CCL2/MCP1 Antibody [NBP2-41209] - Analysis of CCL2 in K562 cell lysate with CCL2 antibody at 1 ug/mL.")
![Immunohistochemistry: CCL2/MCP1 Antibody - BSA Free [NBP2-41209] - Immunohistochemistry of CCL2/MCP1 in human spleen tissue with CCL2/MCP1 antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/nbp2-41209_rabbit-polyclonal-ccl2-mcp1-antibody-2711202420414544.jpg)
![Immunocytochemistry/ Immunofluorescence: CCL2/MCP1 Antibody - BSA Free [NBP2-41209] - Immunofluorescence of CCL2/MCP1 in human spleen tissue with CCL2/MCP1 antibody at 20 ug/ml.](http://images.novusbio.com/fullsize/nbp2-41209_rabbit-polyclonal-ccl2-mcp1-antibody-27112024200419.jpg)
![ELISA: CTLA-4 Antibody (BNI3) [NB100-64849] - Human Anti-Abatacept Antibody bridging ELISA for Pharmacokinetic (PK) assay development A microtiter plate was coated overnight with Mouse Anti-Human CD152 Antibody, clone BNI3 at a concentration of 1 µg/ml. After washing and blocking with PBST + 5% BSA, 10% human serum was added spiked with increasing concentrations of abatacept. Detection was performed using HRP conjugated Human Anti-Abatacept Antibody, clone AbD37058ia at a concentration of 2 µg/ml in HISPEC Assay Diluent followed by QuantaBlu Fluorogenic Peroxidase Substrate. Data are shown as the mean of three measurements. HRP conjugation of the antibody used in this assay was performed using a LYNX Rapid HRP Antibody Conjugation Kit.](http://images.novusbio.com/fullsize/nb100-64849_mouse-monoclonal-ctla-4-antibody-bni3-2312025235988.jpg "ELISA: CTLA-4 Antibody (BNI3) [NB100-64849] - Human Anti-Abatacept Antibody bridging ELISA for Pharmacokinetic (PK) assay development A microtiter plate was coated overnight with Mouse Anti-Human CD152 Antibody, clone BNI3 at a concentration of 1 µg/ml. After washing and blocking with PBST + 5% BSA, 10% human serum was added spiked with increasing concentrations of abatacept. Detection was performed using HRP conjugated Human Anti-Abatacept Antibody, clone AbD37058ia at a concentration of 2 µg/ml in HISPEC Assay Diluent followed by QuantaBlu Fluorogenic Peroxidase Substrate. Data are shown as the mean of three measurements. HRP conjugation of the antibody used in this assay was performed using a LYNX Rapid HRP Antibody Conjugation Kit.")
![Western Blot: Jun Antibody (3G2) [NBP2-02258] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Jun (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Jun.](http://images.novusbio.com/fullsize/Jun-Antibody-3G2-Western-Blot-NBP2-02258-img0004.jpg "Western Blot: Jun Antibody (3G2) [NBP2-02258] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Jun (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Jun.")
![Immunocytochemistry/Immunofluorescence: Jun Antibody (3G2) [NBP2-02258] Staining of COS7 cells transiently transfected by pCMV6-ENTRY Jun.](http://images.novusbio.com/fullsize/Jun-Antibody-3G2-Immunocytochemistry-Immunofluorescence-NBP2-02258-img0005.jpg)
![Flow Cytometry: Jun Antibody (3G2) [NBP2-02258] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-Jun antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/Jun-Antibody-3G2-Flow-Cytometry-NBP2-02258-img0003.jpg)
![Flow Cytometry: Jun Antibody (3G2) [NBP2-02258] - Analysis of Hela cells, using anti-Jun antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/Jun-Antibody-3G2-Flow-Cytometry-NBP2-02258-img0001.jpg)
![Flow Cytometry: Jun Antibody (3G2) [NBP2-02258] - Analysis of Jurkat cells, using anti-Jun antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/Jun-Antibody-3G2-Flow-Cytometry-NBP2-02258-img0002.jpg)
![Flow Cytometry: CD90/Thy1 Antibody (5E10) [NBP1-43379] - Analysis using the PerCP/Cy5.5 conjugate of NBP1-43379. Staining of the HEL cell line with Mouse IgG1 kappa Isotype Control PerCP-Cy5.5 (open histogram) or Anti-Human CD90 (Thy-1) PerCP-Cy5.5 (filled histogram). Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/CD90-Thy1-Antibody-5E10-Flow-Cytometry-NBP1-43379-img0003.jpg "Flow Cytometry: CD90/Thy1 Antibody (5E10) [NBP1-43379] - Analysis using the PerCP/Cy5.5 conjugate of NBP1-43379. Staining of the HEL cell line with Mouse IgG1 kappa Isotype Control PerCP-Cy5.5 (open histogram) or Anti-Human CD90 (Thy-1) PerCP-Cy5.5 (filled histogram). Total viable cells were used for analysis.")
![Flow Cytometry: CD90/Thy1 Antibody (5E10) [NBP1-43379] - Staining of human erythroleukemia (HEL) cell line with 0.25 ug of Mouse IgG1 kappa Isotype Control Purified (NBP1-43319) (open histogram) or 0.25 ug of Anti-Human CD90 (Thy-1) Purified (filled histogram) followed by Anti-Mouse IgG FITC. Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/CD90-Thy1-Antibody-5E10-Flow-Cytometry-NBP1-43379-img0001.jpg)
![Flow Cytometry: HLA DQ/DR/DP Antibody (WR18) [NB100-64358] - Staining of human peripheral blood lymphocytes.](http://images.novusbio.com/fullsize/HLA-DQ-DR-DP-Antibody-WR18-Flow-Cytometry-NB100-64358-img0001.jpg "Flow Cytometry: HLA DQ/DR/DP Antibody (WR18) [NB100-64358] - Staining of human peripheral blood lymphocytes.")
![CyTOF-ready: Lysozyme Antibody (BGN/0696/5B1) [NB100-63062] - Human bone marrow after RBC lysis was stained with surface antibodies, fixed, permeabilized with methanol, stained with anti-lysozyme NB100-63062, and gated for the above populations per Nat Med. 2020. 26:408-417. CyTOF image submitted by a verified customer review.](http://images.novusbio.com/fullsize/Lysozyme-Antibody-BGN-0696-5B1-CyTOF-ready-NB100-63062-img0001.jpg "CyTOF-ready: Lysozyme Antibody (BGN/0696/5B1) [NB100-63062] - Human bone marrow after RBC lysis was stained with surface antibodies, fixed, permeabilized with methanol, stained with anti-lysozyme NB100-63062, and gated for the above populations per Nat Med. 2020. 26:408-417. CyTOF image submitted by a verified customer review.")